Cigna Healthcare, Infirmary Health Reach Medicare Advantage Agreement

Go back to Cigna Healthcare, Infirmary Health Reach Medicare Advantage Agreement

CIGNA (CI) PT Raised to $394 at Piper Sandler

November 4, 2024 4:04 PM EST

Piper Sandler analyst Jessica Tassan raised the price target on CIGNA (NYSE: CI) to $394.00 (from $392.00) while maintaining a Overweight rating.

The analyst comments "CI reported a pharmacy-led 3Q24 adjusted EPS beat and reiterated adjusted CY24 guidance. Notwithstanding the asset sale at Cigna Healthcare and... More